1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow MYC Gene Rearrangement: new trials by email Literature Review of MYC Gene Rearrangement trials Research Report on MYC Gene Rearrangement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement Lenalidomide, Rituximab, Etoposide - DLBCL, Untreated | Phase 1 / Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 81 | 2020-06-09 | 2020-06-16 |
Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Lenalidomide (1) · Prednisone (1) · Rituximab (1) · Vincristine (1)
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)